PREVALENCE OF MUTATIONS IN EGFR, KRAS AND BRAF IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) AS ASSESSED BY A PANEL OF PCR-BASED ASSAYS

被引:0
|
作者
O'Donnell, Patrick
Current, Robert
Ferguson, Jane
Chien, Shih-Chang
Wen, Wei
Tsan, Alison
Newton, Nick
Jung, Laura
Bauer, Keith
Langland, Rachel
Brophy, Victoria
Schoenbrunner, Nancy
Myers, Thomas
Soviero, Stephen
Lawrence, Jeffrey
Wu, Lin
机构
关键词
EGFR mutations; Kras mutations; BRAF mutations; molecular diagnostics;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S1533 / S1534
页数:2
相关论文
共 50 条
  • [41] Sequential treatment in advanced non-small cell lung cancer harboring EGFR mutations
    Hsu, Ping-Chih
    Chang, John Wen-Cheng
    Chang, Ching-Fu
    Huang, Chen-Yang
    Yang, Cheng-Ta
    Kuo, Chih-Hsi Scott
    Fang, Yueh-Fu
    Wu, Chiao-En
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [42] MILIARY METASTASES ARE ASSOCIATED WITH EGFR MUTATIONS IN ADVANCED NON-SMALL CELL LUNG CANCER
    Hsu, Fred
    Toriumi, Ted
    De Caluwe, Alex
    RADIOTHERAPY AND ONCOLOGY, 2016, 120 : S57 - S57
  • [43] Predictive value of KRAS mutations in advanced non-small cell lung cancer (NSCLC) patients (pts) treated with chemotherapy (CT)
    Dingemans, Anne-Marie C.
    Smit, Egbert F.
    Derks, Jules
    Mellema, Wouter
    Heideman, Danielle
    Van Suylen, Robertjan
    Thunnissen, Erik
    CANCER RESEARCH, 2011, 71
  • [44] Validation study of direct sequencing and PCR-invader for detecting EGFR mutations in non-small cell lung cancer (NSCLC)
    Naito, Y.
    Goto, K.
    Kenmotsu, H.
    Nishiwaki, Y.
    Kubota, K.
    Ohmatsu, H.
    Niho, S.
    Yoh, K.
    Nagai, K.
    Saijo, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [45] EGFR, ALK, RET, KRAS and BRAF alterations in never-smokers with non-small cell lung cancer
    Dong, Yu
    Ren, Weihong
    Qi, Jun
    Jin, Bo
    Li, Ying
    Tao, Huiqing
    Xu, Ren
    Li, Yanqing
    Zhang, Qinxian
    Han, Baohui
    ONCOLOGY LETTERS, 2016, 11 (04) : 2371 - 2378
  • [46] Non-small cell Lung Cancer (NSCLC) with BRAF-Mutations - A single center Observational Study
    Lips, C.
    Rafflenbeul, G.
    Blum, T. G.
    Kollmeier, J.
    Misch, D.
    Schaefer, M.
    Stephan-Falkenau, S.
    Streubel, A.
    Thiel, S.
    Mairinger, T.
    Bauer, T. T.
    PNEUMOLOGIE, 2020, 74 : S134 - S135
  • [47] Prognostic significance and origin of plasma KRAS mutations in patients with non-small cell lung cancer (NSCLC)
    Gautschi, Oliver
    Ziegler, Annemarie
    Huegli, Barbara
    Gugger, Mathias
    Ratschiller, Daniel
    Mack, Philip C.
    Kung, Hsing-Jien
    Stahel, Rolf A.
    Gandara, David R.
    Betticher, Daniel C.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S443 - S443
  • [48] Exploring the association between KRAS mutations and depression in non-small cell lung cancer (NSCLC) patients
    Li, Jenny Jing
    Harper, Jessica
    Bhulani, Nizar
    Gerber, David E.
    Khan, Saad A.
    Madrigales, Alejandra
    Gates, Samantha
    Toups, Marisa
    Beg, Muhammad Shaalan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (31)
  • [49] KRAS mutations in the circulating free DNA (cfDNA) of non-small cell lung cancer (NSCLC) patients
    Garzon, Monica
    Villatoro, Sergi
    Teixido, Cristina
    Mayo, Clara
    Martinez, Alejandro
    Llanos Gil, Maria de Los
    Viteri, Santiago
    Morales-Espinosa, Daniela
    Rosell, Rafael
    TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (05) : 511 - 516
  • [50] EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer
    Tomasini, Pascale
    Serdjebi, Cindy
    Khobta, Nataliya
    Metellus, Philippe
    Ouafik, L'Houcine
    Nanni, Isabelle
    Greillier, Laurent
    Loundou, Anderson
    Fina, Frederic
    Mascaux, Celine
    Barlesi, Fabrice
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (12)